Vanguard Group’s Terns Pharmaceuticals TERN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.1M | Buy |
4,306,166
+154,010
| +4% | +$574K | ﹤0.01% | 2656 |
|
|
2025
Q1 | $11.5M | Buy |
4,152,156
+282,574
| +7% | +$780K | ﹤0.01% | 2766 |
|
|
2024
Q4 | $21.4M | Buy |
3,869,582
+512,768
| +15% | +$2.84M | ﹤0.01% | 2553 |
|
|
2024
Q3 | $28M | Buy |
3,356,814
+1,055,872
| +46% | +$8.81M | ﹤0.01% | 2431 |
|
|
2024
Q2 | $15.7M | Buy |
2,300,942
+101,936
| +5% | +$694K | ﹤0.01% | 2688 |
|
|
2024
Q1 | $14.4M | Buy |
2,199,006
+11,535
| +0.5% | +$75.7K | ﹤0.01% | 2762 |
|
|
2023
Q4 | $14.2M | Sell |
2,187,471
-14,643
| -0.7% | -$95K | ﹤0.01% | 2759 |
|
|
2023
Q3 | $11.1M | Sell |
2,202,114
-23,157
| -1% | -$116K | ﹤0.01% | 2830 |
|
|
2023
Q2 | $19.5M | Buy |
2,225,271
+934,022
| +72% | +$8.17M | ﹤0.01% | 2598 |
|
|
2023
Q1 | $15.3M | Buy |
1,291,249
+165,213
| +15% | +$1.96M | ﹤0.01% | 2721 |
|
|
2022
Q4 | $11.5M | Buy |
1,126,036
+506,904
| +82% | +$5.16M | ﹤0.01% | 2890 |
|
|
2022
Q3 | $3.65M | Buy |
619,132
+251,603
| +68% | +$1.48M | ﹤0.01% | 3487 |
|
|
2022
Q2 | $912K | Sell |
367,529
-65,490
| -15% | -$163K | ﹤0.01% | 4119 |
|
|
2022
Q1 | $1.29M | Sell |
433,019
-125,308
| -22% | -$372K | ﹤0.01% | 4131 |
|
|
2021
Q4 | $3.95M | Buy |
558,327
+117,655
| +27% | +$832K | ﹤0.01% | 3739 |
|
|
2021
Q3 | $4.59M | Buy |
440,672
+24,942
| +6% | +$260K | ﹤0.01% | 3718 |
|
|
2021
Q2 | $5.1M | Sell |
415,730
-160,063
| -28% | -$1.96M | ﹤0.01% | 3598 |
|
|
2021
Q1 | $12.7M | Buy |
+575,793
| New | +$12.7M | ﹤0.01% | 3023 |
|